Suppr超能文献

脊髓性肌萎缩症也是一种精子发生障碍。

Spinal muscular atrophy is also a disorder of spermatogenesis.

作者信息

Magot Armelle, Reignier Arnaud, Binois Olivier, Bedat-Millet Anne Laure, Davion Jean-Baptiste, Debergé Louise, Ghorab Karima, Guyant Lucie, Laheranne Émilie, Laforet Pascal, Lefeuvre Claire, Mallaret Martial, Michaud Maud, Omar Chahla, Nadaj-Pakleza Aleksandra, Nicolas Guillaume, Noury Jean Baptiste, Pegat Antoine, Péré Morgane, Salort-Campana Emmanuelle, Sole Guilhem, Spinazzi Marco, Tard Céline, Vuillerot Carole, Péréon Yann

机构信息

Centre de Référence Des Maladies Neuromusculaires AOC, CHU de Nantes, Filnemus, Euro-NMD, Hôtel Dieu, Nantes, France.

Service de Médecine Et Biologie de La Reproduction, Gynécologie Médicale, CHU de Nantes, Nantes, France.

出版信息

Orphanet J Rare Dis. 2024 Dec 20;19(1):476. doi: 10.1186/s13023-024-03494-2.

Abstract

BACKGROUND

Spinal muscular atrophy (SMA) patients benefit from pre-mRNA splicing modifiers targeting the SMN2 gene, which aims to increase functional SMN production. The animal toxicity affecting spermatogenesis associated with one such treatment raised questions about male SMA patients' spermatogenesis.

METHODS

This descriptive, cross-sectional study was conducted from June 2022 to July 2023. The study involved adult male patients with genetically confirmed SMA type 2 (SMA2) or SMA3 from 13 French neuromuscular centers. The patients' general data, motor severity, urological history, exposure to certain factors, parenthood, and spermogram results were obtained. All patients were enrolled prior to exposure to risdiplam.

FINDINGS

Sixty-eight patients were enrolled ( 36 SMA2 and 32 SMA3 patients). Forty-one patients had fertility data (parenthood history and spermogram analyses) and underwent 33 spermograms. Fertility disorders were identified in 27 of the 41 patients (65·9%, 95%CI 51·3-80·4%) in particular SMA2 patients: 19 cases (905%, CI 77·9-100%) (SMA3: 8 cases (40%, CI 18·5-61·5%). Among the patients with available spermograms, 81% (27/33) had abnormal sperm concentration; 30% presented azoospermia. These abnormalities were significantly associated with SMA type (more prevalent in SMA2 patients, p < 0·001), disease motor severity, which included age at the loss of walking ability and wheelchair use duration (p < 0·001). The Motor Function Measure (MFM) determined that the sperm counts were also correlated with disease severity (p < 0·01).

INTERPRETATION

The fertility disorders were correlated with SMA severity and were particularly evident in SMA2 patients. In the latter, sperm concentration positively correlated with MFM. This study is the first one to link fertility disorders with spermogram abnormalities in SMA males. Understanding spermatogenesis in SMA is crucial, especially with new therapies such as risdiplam. Consequently, conducting systematic spermogram studies prior to SMA treatment is recommended.

摘要

背景

脊髓性肌萎缩症(SMA)患者可从靶向SMN2基因的前体mRNA剪接修饰剂中获益,该修饰剂旨在增加功能性SMN的产生。一种此类治疗方法对精子发生的动物毒性引发了关于男性SMA患者精子发生的疑问。

方法

本描述性横断面研究于2022年6月至2023年7月进行。该研究纳入了来自13个法国神经肌肉中心的成年男性2型SMA(SMA2)或3型SMA(SMA3)基因确诊患者。获取了患者的一般资料、运动严重程度、泌尿系统病史、接触某些因素情况、生育情况及精液分析结果。所有患者均在接受利司扑兰治疗前入组。

结果

共纳入68例患者(36例SMA2患者和32例SMA3患者)。41例患者有生育数据(生育史和精液分析)并进行了33次精液分析。41例患者中有27例(65.9%,95%CI 51.

3 - 80.4%)存在生育障碍,尤其是SMA2患者:19例(90.5%,CI 77.9 - 100%)(SMA3:8例(40%,CI 18.5 - 61.5%)。在有精液分析结果的患者中,81%(27/33)精子浓度异常;30%无精子症。这些异常与SMA类型显著相关(在SMA2患者中更常见,p < 0.001),与疾病运动严重程度相关,包括丧失行走能力的年龄和使用轮椅的时长(p < 0.001)。运动功能测量(MFM)显示精子计数也与疾病严重程度相关(p < 0.01)。

解读

生育障碍与SMA严重程度相关,在SMA2患者中尤为明显。在后者中,精子浓度与MFM呈正相关。本研究是首个将生育障碍与SMA男性精液分析异常联系起来的研究。了解SMA中的精子发生至关重要,尤其是对于利司扑兰等新疗法。因此,建议在SMA治疗前进行系统的精液分析研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a9/11662785/7006d4f87d05/13023_2024_3494_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验